IQV Stock Price - IQVIA Holdings Inc. logo

IQV Stock Price

IQVIA Holdings Inc.

$262.01
+$1.33(+0.51%)
51
Overall
60
Value
45
Tech
50
Quality
How is this score calculated?
Market Cap
$42.91B
Volume
1.12M
52W Range
$154.50 - $277.40
Target Price
$293.05

IQV stock price is $262.01 (+0.51% on the day), giving IQVIA Holdings Inc. a market cap of $42.91B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.

IQV Stock Overview

Price
$262.01
Previous close
$260.68
Open
$264.37
Market cap
$42.91B
P/E ratio
31.5
52-week range
$154.50 - $277.40
1-year price target
$293.05
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
NYE
MarketXLS Rank
51

About IQVIA Holdings Inc.

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is based in Durham, North Carolina.

ABCD
1SymbolPriceChangeVol
2IQV$262.01+0.5%1.12M
3
4
5
6

Get IQVIA Holdings Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.